The impact on the healthcare system can be up to $45,000 to treat a single bedsore, and some pay the ultimate price. 60,000 people in the U.S. alone die each year from these highly preventable pressure ulcers. Dr. Sanna Gaspard, CEO of Rubitection, is passionate about changing the outcomes. She speaks with Dr. Sujatha Ramanujan, Managing Director for the Luminate accelerator, about her company’s skin health monitoring platform, the Rubitect Assessment System (RAS), which offers a more reliable and effective alternative to the manual blanch test for bedsore detection. Hear what inspired the development of the RAS, the implications for the management of other skin conditions, and how Dr. Gaspard’s experience in the Luminate accelerator benefited her startup.